Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Avitene is a brand-name, absorbable microfibrillar collagen hemostat used to control bleeding during surgical procedures. It is derived from purified bovine collagen and functions by accelerating clot formation at the site of application. The mechanism involves enhancing platelet aggregation and promoting the release of proteins that form fibrin, resulting in rapid hemostasis. Avitene is indicated for use in a wide range of surgeries—including neurosurgery, dental surgery, liver and spleen operations—especially where traditional methods like sutures or cauterization may not be sufficient. It conforms to irregular spaces, adheres well to tissue, and can be easily removed with irrigation or suction if necessary[1][2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on avitene.